Intraoperative radiotherapy during breast-conserving surgery using a miniature x-ray generator (Intrabeam®): Theoretical and experimental background and clinical experience

Women's Health

Volumn 8, Issue 1, 2012, Pages 39-47

  Wenz, Frederik ^a   Blank, Elena ^a   Welzel, Grit ^a   Hofmann, Frank ^a   Astor, Daniela ^a   Neumaier, Christian ^a   Herskind, Carsten ^a   Gerhardt, Axel ^a   Suetterlin, Marc ^a   Kraus Tiefenbacher, Uta ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

accelerated partial breast irradiation; boost; breast cancer; intraoperative radiotherapy; late effects; quality of life

Indexed keywords

ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL PRACTICE; EXPERIMENTAL STUDY; GENERATOR; HUMAN; HYPERPIGMENTATION; IN VITRO STUDY; INTRAOPERATIVE RADIOTHERAPY; PARTIAL MASTECTOMY; TELANGIECTASIA; THEORETICAL STUDY; TUMOR CELL; X RAY;

ADULT; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE CARE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 83755180438     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.11.82     Document Type: Article

References (40)

1. Kraus-Tiefenbacher U, Steil V, Bauer L, Melchert F, Wenz F. A novel device for intraoperative radiotherapy (IORT). Onkologie 26, 596-598 (2003). (Pubitemid 38056749)
2. Vaidya JS, Tobias JS, Baum M et al. Intraoperative radiotherapy for breast cancer. Lancet Oncol. 5, 165-173 (2004). (Pubitemid 38262848)
3. Vaidya J, Tobias JS, Baum M et al. Targeted intraoperative radiotherapy (TARGIT) - an innovative approach to partial breast irradiation. Semin. Radiat. Oncol. 15, 84-91 (2005). (Pubitemid 40432412)
4. Clarke M, Collins R, Darby S et al.; Early Breast Cancer Trialists' Collaborative Group. Effect of radiotherapy and of differences in extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview on randomized trials. Lancet 366, 2087-2106 (2005). (Pubitemid 41797643)
5. Abo Madyan Y, Polednik M, Rahn A et al. Improving dose homogeneity in large breast by IMRT: efficacy and dosimetric accuracy of different techniques. Strahlenther. Onkol. 184, 86-92 (2008). (Pubitemid 351231652)
6. Lohr F, Heggemann F, Papavassiliu T et al. Ist die kardiotoxizität der radiotherapie im rahmen des brusterhalts uberhaupt noch relevant, und könnte sie durch mehrfelder- IMRT gesenkt werden? Strahlenther. Onkol. 185, 222-230 (2009).
7. Lohr F, El-Haddad M, Dobler B et al. Potential impact of a robust and simple IMRT approach for left sided breast cancer on cardiac mortality Int. J. Radiat. Oncol. Biol. Phys. 74, 73-80 (2009).
8. Bartelink H, Horiot JC, Poortmans P et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N. Engl. J. Med. 345, 1378-1387 (2001).
9. Fisher B, Bryant J, Dignam JJ et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J. Clin. Oncol. 20, 4141-4149 (2002). (Pubitemid 35191016)
10. Hughes KS, Schnaper LA, Berry D et al. Lumpectomy plus Tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N. Engl. J. Med. 351, 971-977 (2004). (Pubitemid 39166260)
11. Fyles AW, McCready DR, Manchul LA et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N. Engl. J. Med. 351, 963-970 (2004).
12. Pötter R, Gnant M, Kwasny W et al. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 68, 334-340 (2007). (Pubitemid 46694171)
13. Veronesi U, Orecchia R, Luini A et al. Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res. Treat. 124(1), 141-151 (2010).
14. Benda RK, Yasuda G, Sethi A et al. Breast boost: are we missing the target? Cancer 97, 905-909 (2003).
15. Huang J, Barbera L, Brouwers M et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J. Clin. Oncol. 21, 555-563 (2003). (Pubitemid 46606487)
16. Herskind C, Griebel J, Kraus-Tiefenbacher U, Wenz F. Sphere of equivalence - a novel target volume concept for intraoperative radiotherapy using low-energy x rays. Int. J. Radiat. Oncol. Biol. Phys. 72, 1575-1581 (2008).
17. Sautter-Bihl ML, Budach W, Dunst J et al. DEGRO practical guidelines for radiotherapy of breast cancer I. Strahlenther. Onkol. 183, 661-666 (2007). (Pubitemid 350175416)
18. Wenz F, Budach W, Dunst J et al. Accelerated partial breast irradiation (APBI) - ready for prime time? Strahlenther. Onkol. 185, 653-655 (2009).
19. Souchon R, Wenz F, Sedlmayer F et al. DEGRO practice guidelines for palliative radiotherapy of metastastic breast cancer. Strahlenther. Onkol. 185, 417-424 (2009).
20. Sautter-Bihl ML, Sedlmayer F, Budach W et al. Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer - beware of one-stop shops? Strahlenther. Onkol. 186, 651-657 (2010).
21. Holland R, Veling SH, Mravunac M et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-concerving surgery. Cancer 56, 979-990 (1985). (Pubitemid 15003474)
22. Herskind C, Steil V, Tiefenbacher U, Wenz F. Radiobiologic aspects of intraoperative radiotherapy (IORT) with isotropic low-energy x rays for early-stage breast cancer. Radiat. Res. 163, 208-215 (2005). (Pubitemid 40170771)
23. Herskind C, Schalla S, Hahn EW, Höver KH, Wenz F. Influence of different dose rates on cell recovery and RBE at different spatial positions during protracted conformal radiotherapy. Radiat. Protect. Dosim. 122, 498-505 (2006). (Pubitemid 47090514)
24. Herskind C, Wenz F. Radiobiological comparison of hypofractionated accelerated partial breast irradiation (APBI) and single-dose intraoperative radiotherapy (IORT) with 50-kV x rays. Strahlenther. Onkol. 186, 444-451 (2010).
25. Kraus-Tiefenbacher U, Scheda A, Steil V et al. Intraoperative radiotherapy (IORT) for breast cancer using the INTRABEAM system. Tumori 91, 339-345 (2005). (Pubitemid 41433127)
26. Kraus-Tiefenbacher U, Scheda A, Bauer L, Kehrer T, Melchert F, Wenz F. Intraoperative radiotherapy (IORT) as a boost in patients with early stage breast cancer - acute toxicity. Onkologie 29, 77-82 (2006). (Pubitemid 43341001)
27. Kraus-Tiefenbacher U, Bauer L, Scheda A et al. Long-term toxicity of an intraoperative radiotherapy (IORT) boost using low energy x rays during breast conserving surgery (BCS). Int. J. Radiat. Oncol. Biol. Phys. 66, 377-381 (2006). (Pubitemid 44332741)
28. Kraus-Tiefenbacher U, Welzel G, Brade J et al. Postoperative seroma formation after intraoperative radiotherapy (IORT) using low KV x rays given during breast conserving surgery. Int. J. Radiat. Oncol. Biol. Phys. 77, 1140-1145 (2010).
29. Vaidya J, Baum M, Tobias JS et al. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost. Int. J. Radiat. Oncol. Biol. Phys. 66, 1335-1338 (2006).
30. Vaidya JS, Joseph DJ, Tobias JS et al. TARGeted Intraoperative radioTherapy Alone versus whole breast radiotherapy for breast cancer (TARGIT-A trial)- results of an international prospective randomised Phase III trial. Lancet 376, 91-102 (2010).
31. Vaidya JS, Baum M, Tobias JS et al. Long term results of targeted intraoperative radiotherapy (TARGIT) boost during breast conserving surgery. Int. J. Radiat. Oncol. Biol. Phys. 81(4), 1091-1097 (2011).
32. Wenz F, Welzel G, Blank E et al. Intraoperative radiotherapy (IORT) as a boost during breast conserving surgery (BCS) using low kV x rays - the first five years of experience with a novel approach. Int. J. Radiat. Oncol. Biol. Phys. 77, 1309-1314 (2010).
33. Blank E, Kraus-Tiefenbacher U, Keller A et al. Single center long term follow-up after intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage x rays. Ann. Surg. Oncol. 17(Suppl. 3), 352-358 (2010).
34. Keshtgar M, Vaidya JS, Tobias JS et al. Targeted intra-operative radiotherapy (TARGIT) for breast cancer in patients where external beam radiation is not possible. Int. J. Radiat. Oncol. Biol. Phys. 80, 31-38 (2011).
35. Welzel G, Hofmann F, Blank E et al. Health related quality of life after breast conserving surgery and intraoperative radiotherapy for breast cancer using low-kilovolt x rays. Ann. Surg. Oncol. 17(Suppl. 3), 359-367 (2010).
36. Wasser K, Schoeber C, Kraus-Tiefenbacher U et al. Early mammographic and sonographic findings after intraoperative radiotherapy (IORT) as a boost in patients with breast cancer. Eur. J. Radiol. 17, 1865-1874 (2007). (Pubitemid 46909677)
37. Ruch M, Brade J, Schoeber C et al. Long-term follow-up findings in mammography and ultrasound after intraoperative radiotherapy (IORT) for breast cancer. Breast 18, 327-334 (2009).
38. Wasser K, Ruch M, Brade J et al. Do structural changes in the tumor bed after intraoperative radiotherapy (IORT) of breast cancer complicate the evaluation of mammograms in a long-term follow-up? Eur. J. Radiol. doi:10.1016/j. ejrad.2011.02.016 (2011) (Epub ahead of print).
39. Kraus-Tiefenbacher U, Bauer L, Schöber C, Schaefer J, Steil V, Wenz F. Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy. BMC Cancer 7, 178 (2007).
40. Kraus-Tiefenbacher U, Blank E, Wenz F. Intraoperative Radiotherapy (IORT) during a second breast-conserving procedure for relapsed breast cancer after previous external beam radiotherapy (EBRT). Int. J. Radiat. Oncol. Biol. Phys. 80, 1279-1280 (2011).